ALERS logo

Eurobio Scientific Société anonyme Stock Price

ENXTPA:ALERS Community·€247.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

ALERS Share Price Performance

€24.55
-1.15 (-4.47%)
€24.55
-1.15 (-4.47%)
Price €24.55

ALERS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate growth potential.

2 Risks
2 Rewards

Eurobio Scientific Société anonyme Key Details

€162.5m

Revenue

€85.8m

Cost of Revenue

€76.6m

Gross Profit

€74.3m

Other Expenses

€2.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.23
47.17%
1.45%
6.2%
View Full Analysis

About ALERS

Founded
1997
Employees
380
CEO
Denis Fortier
WebsiteView website
www.eurobio-scientific.com

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus; and EBX molecular biology range, which includes a range of tests for identifying various pathogens responsible for infectious diseases. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

Recent ALERS News & Updates

Recent updates

No updates